Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator

Stroke

Volumn 45, Issue 7, 2014, Pages 2030-2035

  Leigh, Richard ^a   Jen, Shyian S ^b   Hillis, Argye E ^a   Krakauer, John W ^a   Barker, Peter B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood brain barrier; magnetic resonance imaging; stroke

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BLOOD BRAIN BARRIER; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; FEMALE; FOLLOW UP; HEMISPHERE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL;

BLOOD-BRAIN BARRIER; MAGNETIC RESONANCE IMAGING; STROKE;

AGED; AGED, 80 AND OVER; BLOOD-BRAIN BARRIER; BRAIN ISCHEMIA; CAPILLARY PERMEABILITY; CEREBRAL INFARCTION; DATABASES, FACTUAL; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 84903733903     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.005249     Document Type: Article

References (27)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333: 1581-1587.
2. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D, et al ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med. 2008;359: 1317-1329.
3. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274: 1017-1025.
4. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke. 1997;28: 2109-2118.
5. Hjort N, Wu O, Ashkanian M, Sølling C, Mouridsen K, Christensen S, et al. MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis. Stroke. 2008;39: 1025-1028. (Pubitemid 351619569)
6. Kim EY, Na DG, Kim SS, Lee KH, Ryoo JW, Kim HK. Prediction of hemorrhagic transformation in acute ischemic stroke: role of diffusionweighted imaging and early parenchymal enhancement. AJNR Am J Neuroradiol. 2005;26: 1050-1055. (Pubitemid 43821947)
7. Jiang Q, Zhang RL, Zhang ZG, Knight RA, Ewing JR, Ding G, et al. Magnetic resonance imaging characterization of hemorrhagic transformation of embolic stroke in the rat. J Cereb Blood Flow Metab. 2002;22: 559-568. (Pubitemid 34477777)
8. Knight RA, Barker PB, Fagan SC, Li Y, Jacobs MA, Welch KM. Prediction of impending hemorrhagic transformation in ischemic stroke using magnetic resonance imaging in rats. Stroke. 1998;29: 144-151. (Pubitemid 28046957)
9. Wintermark M, Albers GW, Alexandrov AV, Alger JR, Bammer R, Baron JC, et al. Acute stroke imaging research roadmap. Stroke. 2008;39: 1621-1628.
10. Latour LL, Kang DW, Ezzeddine MA, Chalela JA, Warach S. Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004;56: 468-477. (Pubitemid 39319336)
11. Warach S, Latour LL. Evidence of reperfusion injury, exacerbated by thrombolytic therapy, in human focal brain ischemia using a novel imaging marker of early blood-brain barrier disruption. Stroke. 2004;35(11 suppl 1): 2659-2661. (Pubitemid 39458362)
12. Bang OY, Buck BH, Saver JL, Alger JR, Yoon SR, Starkman S, et al. Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol. 2007;62: 170-176. (Pubitemid 47546502)
13. Mlynash M, Lansberg MG, De Silva DA, Lee J, Christensen S, Straka M, et al DEFUSE-EPITHET Investigators. Refining the definition of the malignant profile: insights from the DEFUSE-EPITHET pooled data set. Stroke. 2011;42: 1270-1275.
14. Zaharchuk G. Theoretical basis of hemodynamic MR imaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol. 2007;28: 1850-1858. (Pubitemid 350174722)
15. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol. 2006;27: 859-867. (Pubitemid 44897737)
16. Leigh R, Jen SS, Varma DD, Hillis AE, Barker PB. Arrival time correction for dynamic susceptibility contrast MR permeability imaging in stroke patients. PLoS One. 2012;7:e52656.
17. Iadecola C, Nedergaard M. Glial regulation of the cerebral microvasculature. Nat Neurosci. 2007;10: 1369-1376. (Pubitemid 350014688)
18. Yang Y, Rosenberg GA. Blood-brain barrier breakdown in acute and chronic cerebrovascular disease. Stroke. 2011;42: 3323-3328.
19. Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke. 2004;35(11 suppl 1): 2726-2730. (Pubitemid 39458380)
20. Jickling GC, Liu D, Stamova B, Ander BP, Zhan X, Lu A, et al. Hemorrhagic transformation after ischemic stroke in animals and humans. J Cereb Blood Flow Metab. 2014;34: 185-199.
21. Kidwell CS, Burgess R, Menon R, Warach S, Latour LL. Hyperacute injury marker (HARM) in primary hemorrhage: A distinct form of CNS barrier disruption. Neurology. 2011;77: 1725-1728.
22. Thornhill RE, Chen S, Rammo W, Mikulis DJ, Kassner A. Contrastenhanced MR imaging in acute ischemic stroke: T2* measures of bloodbrain barrier permeability and their relationship to T1 estimates and hemorrhagic transformation. AJNR Am J Neuroradiol. 2010;31: 1015-1022.
23. Wu S, Thornhill RE, Chen S, Rammo W, Mikulis DJ, Kassner A. Relative recirculation: A fast, model-free surrogate for the measurement of bloodbrain barrier permeability and the prediction of hemorrhagic transformation in acute ischemic stroke. Invest Radiol. 2009;44: 662-668.
24. Scalzo F, Alger JR, Hu X, Saver JL, Dani KA, Muir KW, et al STIR/ VISTA Imaging Investigators. Multi-center prediction of hemorrhagic transformation in acute ischemic stroke using permeability imaging features. Magn Reson Imaging. 2013;31: 961-969.
25. Ewing JR, Knight RA, Nagaraja TN, Yee JS, Nagesh V, Whitton PA, et al. Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening. Magn Reson Med. 2003;50: 283-292. (Pubitemid 36950847)
26. Leigh R, Zaidat OO, Suri MF, Lynch G, Sundararajan S, Sunshine JL, et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke. 2004;35: 1903-1907. (Pubitemid 38971873)
27. Lapchak PA, Chapman DF, Zivin JA. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke. Stroke. 2000;31: 3034-3040.